EyePoint Pharmaceuticals Inc. buy Guggenheim
Start price
24.06.26
/
50%
€13.00
Target price
24.06.27
€59.83
Performance (%)
-6.92%
Price
26.06.26
€11.50
Summary
This prediction is currently active. With a performance of -6.92%, the BUY prediction by Guggenheim is trending in the wrong direction. This prediction currently runs until 24.06.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| EyePoint Pharmaceuticals Inc. | -6.92% |
| iShares Core DAX® | -1,36 % |
| iShares Nasdaq 100 | -3,70 % |
| iShares Nikkei 225® | -2,51 % |
| iShares S&P 500 | -1,66 % |
Comments by Guggenheim for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
Eyepoint Pharmaceuticals (EYPT) had its "buy" rating reaffirmed by Guggenheim. They now have a $68.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat